help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HILL, A. T.
Right arrow Articles by STOCKLEY, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HILL, A. T.
Right arrow Articles by STOCKLEY, R. A.

Am. J. Respir. Crit. Care Med., Volume 160, Number 6, December 1999, 1968-1975

Evidence for Excessive Bronchial Inflammation during an Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Patients with alpha 1-Antitrypsin Deficiency (PiZ)

ADAM T. HILL, EDWARD J. CAMPBELL, DARREN L. BAYLEY, SUSAN L. HILL, and ROBERT A. STOCKLEY

Department of Medicine, Queen Elizabeth Hospital, Edgbaston, Birmingham, United Kingdom; and Department of Medicine, University of Utah Health Sciences Center, Salt Lake City, Utah

Patients with homozygous (PiZ) alpha 1-antitrypsin (AAT) deficiency have not only low baseline serum AAT levels (approximately 10 to 15% normal) but also an attenuated acute phase response. They are susceptible to the development of premature emphysema but may also be particularly susceptible to lung damage during bacterial exacerbations when there will be a significant neutrophil influx. The purposes of the present study were to assess the inflammatory nature of acute bacterial exacerbations of chronic obstructive pulmonary disease (COPD) in subjects with AAT deficiency, to compare this with COPD patients without deficiency, and to monitor the inflammatory process and its resolution following appropriate antibacterial therapy. At the start of the exacerbation, patients with AAT deficiency had lower sputum AAT (p < 0.001) and secretory leukoprotease inhibitor (SLPI; p = 0.02) with higher elastase activity (p = 0.02) compared with COPD patients without deficiency. Both groups had a comparable acute phase response as assessed by C-reactive protein (CRP) but the AAT-deficient patients had a minimal rise in serum AAT (to < 6 µM). After treatment with antibiotics, in patients with AAT deficiency, there were significant changes in many sputum proteins including a rise in SLPI levels, and a reduction in myeloperoxidase (MPO) and elastase activity (p < 0.005 for all measures); the sputum chemoattractants interleukin-8 (IL-8) and leukotriene B4 (LTB4) fell (p < 0.01), and protein leak (sputum/serum albumin ratio) became lower (p < 0.01). The changes were rapid and within 3 d of the commencement of antibiotic therapy the biochemical markers had decreased significantly, but took a variable time thereafter to return to baseline values. In conclusion, patients with AAT deficiency had evidence of increased elastase activity at the start of the exacerbation when compared with nondeficient COPD patients which probably reflects a deficient antiproteinase screen (lower sputum AAT and SLPI). The increased bronchial inflammation at presentation resolved rapidly with 14 d of antibiotic therapy. Hill AT, Campbell EJ, Bayley DL, Hill SL, Stockley RA. Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with alpha 1-antitrypsin deficiency (PiZ).




This article has been cited by other articles:


Home page
 Eur Respir JHome page
B. Gooptu, U. I. Ekeowa, and D. A. Lomas
Mechanisms of emphysema in {alpha}1-antitrypsin deficiency: molecular and cellular insights
Eur. Respir. J., August 1, 2009; 34(2): 475 - 488.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
Z. Li, S. Alam, J. Wang, C. S. Sandstrom, S. Janciauskiene, and R. Mahadeva
Oxidized {alpha}1-antitrypsin stimulates the release of monocyte chemotactic protein-1 from lung epithelial cells: potential role in emphysema
Am J Physiol Lung Cell Mol Physiol, August 1, 2009; 297(2): L388 - L400.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
A. Dirksen, E. Piitulainen, D. G. Parr, C. Deng, M. Wencker, S. B. Shaker, and R. A. Stockley
Exploring the role of CT densitometry: a randomised study of augmentation therapy in {alpha}1-antitrypsin deficiency
Eur. Respir. J., June 1, 2009; 33(6): 1345 - 1353.
[Abstract] [Full Text] [PDF]

Home page
 Ther Adv Respir DisHome page
C. J. McAloon, A. M. Wood, S. C. Gough, and R. A. Stockley
Matrix metalloprotease polymorphisms are associated with gas transfer in alpha 1 antitrypsin deficiency
Therapeutic Advances in Respiratory Disease, February 1, 2009; 3(1): 23 - 30.
[Abstract] [PDF]

Home page
 Ther Adv Respir DisHome page
G. Tirado-Conde, B. Lara, and M. Miravitlles
Augmentation therapy for emphysema due to alpha-1-antitrypsin deficiency
Therapeutic Advances in Respiratory Disease, February 1, 2008; 2(1): 13 - 21.
[Abstract] [PDF]

Home page
 Proc Am Thorac SocHome page
E. F. M. Wouters, K. H. Groenewegen, M. A. Dentener, and J. H. J. Vernooy
Systemic Inflammation in Chronic Obstructive Pulmonary Disease: The Role of Exacerbations
Proceedings of the ATS, December 1, 2007; 4(8): 626 - 634.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
D. Stolz, M. Christ-Crain, R. Bingisser, J. Leuppi, D. Miedinger, C. Muller, P. Huber, B. Muller, and M. Tamm
Antibiotic Treatment of Exacerbations of COPD: A Randomized, Controlled Trial Comparing Procalcitonin-Guidance With Standard Therapy
Chest, January 1, 2007; 131(1): 9 - 19.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
P Boschetto, S Quintavalle, E Zeni, S Leprotti, A Potena, L Ballerin, A Papi, G Palladini, M Luisetti, L Annovazzi, et al.
Association between markers of emphysema and more severe chronic obstructive pulmonary disease
Thorax, December 1, 2006; 61(12): 1037 - 1042.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
D. A. Lomas
The Selective Advantage of {alpha}1-Antitrypsin Deficiency
Am. J. Respir. Crit. Care Med., May 15, 2006; 173(10): 1072 - 1077.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
P. Mallia and S. L. Johnston
Mechanisms and Experimental Models of Chronic Obstructive Pulmonary Disease Exacerbations
Proceedings of the ATS, November 1, 2005; 2(4): 361 - 366.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
M. Needham and R. A. Stockley
Exacerbations in {alpha}1-antitrypsin deficiency
Eur. Respir. J., June 1, 2005; 25(6): 992 - 1000.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
R. Mahadeva, C. Atkinson, Z. Li, S. Stewart, S. Janciauskiene, D. G. Kelley, J. Parmar, R. Pitman, S. D. Shapiro, and D. A. Lomas
Polymers of Z {alpha}1-Antitrypsin Co-Localize with Neutrophils in Emphysematous Alveoli and Are Chemotactic in Vivo
Am. J. Pathol., February 1, 2005; 166(2): 377 - 386.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
R A Stockley
The HRCT scan pursuing real life pathology
Thorax, October 1, 2004; 59(10): 822 - 823.
[Full Text] [PDF]

Home page
 ThoraxHome page
M Needham and R A Stockley
{alpha}1-Antitrypsin deficiency * 3: Clinical manifestations and natural history
Thorax, May 1, 2004; 59(5): 441 - 445.
[Abstract] [Full Text] [PDF]

Home page
 Proc Am Thorac SocHome page
R. A. Pauwels
Similarities and Differences in Asthma and Chronic Obstructive Pulmonary Disease Exacerbations
Proceedings of the ATS, April 1, 2004; 1(2): 73 - 76.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
A J White, S Gompertz, and R A Stockley
Chronic obstructive pulmonary disease * 6: The aetiology of exacerbations of chronic obstructive pulmonary disease
Thorax, January 1, 2003; 58(1): 73 - 80.
[Abstract] [Full Text] [PDF]

Home page
 J. Appl. Physiol.Home page
R. F. Machado, J. K. Stoller, D. Laskowski, S. Zheng, J. A. Lupica, R. A. Dweik, and S. C. Erzurum
Low levels of nitric oxide and carbon monoxide in alpha 1-antitrypsin deficiency
J Appl Physiol, December 1, 2002; 93(6): 2038 - 2043.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
E F M Wouters
Chronic obstructive pulmonary disease * 5: Systemic effects of COPD
Thorax, December 1, 2002; 57(12): 1067 - 1070.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
L. J. Dowson, P. J. Guest, and R. A. Stockley
The Relationship of Chronic Sputum Expectoration to Physiologic, Radiologic, and Health Status Characteristics in {alpha}1-Antitrypsin Deficiency (PiZ)
Chest, October 1, 2002; 122(4): 1247 - 1255.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
S. Sethi, N. Evans, B. J.B. Grant, and T. F. Murphy
New Strains of Bacteria and Exacerbations of Chronic Obstructive Pulmonary Disease
N. Engl. J. Med., August 15, 2002; 347(7): 465 - 471.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
R. A. Stockley, D. L. Bayley, I. Unsal, and L. J. Dowson
The Effect of Augmentation Therapy on Bronchial Inflammation in {alpha}1-Antitrypsin Deficiency
Am. J. Respir. Crit. Care Med., June 1, 2002; 165(11): 1494 - 1498.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
L. J. DOWSON, P. J. GUEST, and R. A. STOCKLEY
Longitudinal Changes in Physiological, Radiological, and Health Status Measurements in alpha 1-Antitrypsin Deficiency and Factors Associated with Decline
Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1805 - 1809.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
R. A. Stockley, S. Sethi, and T. F. Murphy
Inflammation and Acute Exacerbations of Chronic Bronchitis
Chest, October 1, 2001; 120(4): 1422 - 1423.
[Full Text] [PDF]

Home page
 ThoraxHome page
M A Dentener, E C Creutzberg, A M W J Schols, A Mantovani, C van`t Veer, W A Buurman, and E F M Wouters
Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations
Thorax, September 1, 2001; 56(9): 721 - 726.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
R A Stockley, D Bayley, S L Hill, A T Hill, S Crooks, and E J Campbell
Assessment of airway neutrophils by sputum colour: correlation with airways inflammation
Thorax, May 1, 2001; 56(5): 366 - 372.
[Abstract] [Full Text]

Home page
 ThoraxHome page
A. Hill, S. Gompertz, and R. Stockley
Factors influencing airway inflammation in chronic obstructive pulmonary disease
Thorax, November 1, 2000; 55(11): 970 - 977.
[Full Text]

Home page
 ThoraxHome page
R A Stockley
Alpha-1-antitrypsin deficiency: what next?
Thorax, July 1, 2000; 55(7): 614 - 618.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1999 American Thoracic Society 		  CCM abstracts